As of 2025-09-17, the EV/EBITDA ratio of Crescita Therapeutics Inc (CTX.TO) is -2.26. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTX.TO's latest enterprise value is 1.00 mil CAD. CTX.TO's TTM EBITDA according to its financial statements is -0.45 mil CAD. Dividing these 2 quantities gives us the above CTX.TO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 0.9x - 7.1x | 1.1x |
| Forward P/E multiples | 0.6x - 6.8x | 0.7x |
| Fair Price | 0.38 - 0.24 | 0.38 |
| Upside | -16.3% - -47.0% | -16.4% |
| Date | EV/EBITDA |
| 2025-09-11 | -2.26 |
| 2025-09-10 | -2.47 |
| 2025-09-08 | -2.47 |
| 2025-09-05 | -2.89 |
| 2025-09-03 | -3.32 |
| 2025-09-02 | -3.32 |
| 2025-08-29 | -2.47 |
| 2025-08-27 | -2.47 |
| 2025-08-26 | -2.47 |
| 2025-08-25 | -2.26 |
| 2025-08-22 | -2.47 |
| 2025-08-21 | -2.47 |
| 2025-08-20 | -2.47 |
| 2025-08-19 | -2.89 |
| 2025-08-15 | -3.95 |
| 2025-08-14 | -3.74 |
| 2025-08-13 | -2.47 |
| 2025-08-12 | -3.32 |
| 2025-08-11 | -2.04 |
| 2025-08-08 | -2.89 |
| 2025-08-07 | -2.89 |
| 2025-08-06 | -5.86 |
| 2025-08-05 | -2.89 |
| 2025-08-01 | -2.68 |
| 2025-07-30 | -2.68 |
| 2025-07-28 | -2.89 |
| 2025-07-24 | -2.89 |
| 2025-07-18 | -2.89 |
| 2025-07-17 | -2.68 |
| 2025-07-14 | -3.53 |
| 2025-07-09 | -3.53 |
| 2025-07-08 | -3.53 |
| 2025-07-07 | -3.53 |
| 2025-07-02 | -3.53 |
| 2025-06-30 | -3.95 |
| 2025-06-27 | -3.95 |
| 2025-06-25 | -3.74 |
| 2025-06-24 | -3.53 |
| 2025-06-20 | -3.53 |
| 2025-06-19 | -3.53 |